Wright Medical Group N.V. Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Wright Medical Group N.V. Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance

Jefferies Reiterates Buy on Wright Medical Group (WMGI) Following 4Q

February 22, 2017 7:14 AM EST

Jefferies reiterated a Buy rating and $30.00 price target on Wright Medical Group (NASDAQ: WMGI) following the company's 4Q earnings report.

Analyst Raj Denhoy commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high... More

Needham & Company Maintains Hold Rating on Wright Medical Group (WMGI) Following Strong 4Q16 Results

February 22, 2017 6:26 AM EST

Needham and & Company analyst Mike Matson reiterates Hold rating on Wright Medical Group NV (NASDAQ: WMGI), as the company delivered 2016 fourth quarter revenue and EBITDA above consensus, while offering 2017 revenue guidance above consensus projections.

Matson comments, "WMGI's 4Q16 revenue and EBITDA beat consensus, and... More

Wright Medical Group (WMGI) Posts Q4 Loss of $0.29

February 21, 2017 4:10 PM EST

Wright Medical Group (NASDAQ: WMGI) reported Q4 EPS of ($0.29), which may note compare to the analyst estimate of ($0.11). Revenue for the quarter came in at $193 million versus the consensus estimate of $183.56 million.

GUIDANCE:

Wright Medical Group sees FY2017 revenue of... More